Total Payments
$115,904
2024 Payments
$5,598
Companies
24
Transactions
69
Medicare Patients
1,439
Medicare Billing
$100,308
Payment Breakdown by Category
Consulting$83,510 (72.1%)
Other$21,700 (18.7%)
Research$4,500 (3.9%)
Food & Beverage$3,295 (2.8%)
Education$1,658 (1.4%)
Travel$1,242 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $83,510 | 26 | 72.1% |
| Honoraria | $11,950 | 3 | 10.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,750 | 2 | 8.4% |
| Unspecified | $4,500 | 3 | 3.9% |
| Food and Beverage | $3,295 | 29 | 2.8% |
| Education | $1,658 | 3 | 1.4% |
| Travel and Lodging | $1,242 | 3 | 1.1% |
Payments by Type
General
$111,404
66 transactions
Research
$4,500
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC | $38,157 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $11,061 | 3 | $0 (2022) |
| Evoke Pharma, Inc. | $9,554 | 13 | $0 (2023) |
| Alkermes, Inc. | $9,100 | 2 | $0 (2018) |
| PFIZER INC. | $9,050 | 2 | $0 (2023) |
| Ardelyx, Inc. | $6,206 | 6 | $0 (2024) |
| Amylyx Pharmaceuticals, Inc. | $5,250 | 1 | $0 (2023) |
| Takeda Pharmaceuticals International, Inc. | $5,000 | 1 | $0 (2018) |
| Sebela Pharmaceuticals Inc. | $4,050 | 1 | $0 (2022) |
| US WorldMeds, LLC | $3,673 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,598 | 7 | IRONWOOD PHARMACEUTICALS, INC ($2,100) |
| 2023 | $18,523 | 14 | Amylyx Pharmaceuticals, Inc. ($5,250) |
| 2022 | $21,091 | 17 | Ironwood Pharmaceuticals, Inc ($4,950) |
| 2021 | $12,382 | 4 | PFIZER INC. ($6,050) |
| 2020 | $4,951 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($4,951) |
| 2019 | $147.10 | 1 | Allergan Inc. ($147.10) |
| 2018 | $37,342 | 14 | Ironwood Pharmaceuticals, Inc ($20,000) |
| 2017 | $15,871 | 11 | Ironwood Pharmaceuticals, Inc ($6,585) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 07/25/2024 | IRONWOOD PHARMACEUTICALS, INC | — | — | Cash or cash equivalent | $1,200.00 | Research |
| Study: C3300-201 | ||||||
| 06/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $108.12 | General |
| Category: Gastroenterology | ||||||
| 06/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Education | Cash or cash equivalent | $1,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/20/2024 | Vibrant Gastro, Inc. | Vibrant Starter Kit (Device) | Food and Beverage | In-kind items and services | $142.32 | General |
| Category: Gastroenterology | ||||||
| 04/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $147.55 | General |
| 02/01/2024 | IRONWOOD PHARMACEUTICALS, INC | — | — | Cash or cash equivalent | $900.00 | Research |
| Study: C3300-201 | ||||||
| 10/23/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $67.34 | General |
| Category: Gastroenterology | ||||||
| 10/22/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $144.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/13/2023 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| Category: RETT SYNDROME | ||||||
| 09/15/2023 | Amylyx Pharmaceuticals, Inc. | RELYVRIO (Drug) | Honoraria | Cash or cash equivalent | $5,250.00 | General |
| Category: NEUROLOGY | ||||||
| 07/11/2023 | Micro-tech Endoscopy USA, Inc. | Flat Wire Snares (Device) | Food and Beverage | Cash or cash equivalent | $127.06 | General |
| Category: GI Endoscopy | ||||||
| 06/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $122.64 | General |
| Category: Gastroenterology | ||||||
| 06/01/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $146.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $136.65 | General |
| Category: Gastroenterology | ||||||
| 05/04/2023 | Ironwood Pharmaceuticals, Inc | — | — | Cash or cash equivalent | $2,400.00 | Research |
| Study: C3300-201 | ||||||
| 02/17/2023 | PFIZER INC. | VELSIPITY (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 01/28/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Honoraria | Cash or cash equivalent | $3,700.00 | General |
| Category: Gastroenterology | ||||||
| 01/28/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Travel and Lodging | Cash or cash equivalent | $862.41 | General |
| Category: Gastroenterology | ||||||
| 01/28/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $229.81 | General |
| Category: Gastroenterology | ||||||
| 01/27/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $135.92 | General |
| Category: Gastroenterology | ||||||
| 11/16/2022 | Ironwood Pharmaceuticals, Inc | — | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| 10/23/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $164.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $85.40 | General |
| Category: Gastroenterology | ||||||
| 06/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $64.61 | General |
| Category: Gastroenterology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| C3300-201 | Ironwood Pharmaceuticals, Inc | $2,400 | 1 |
| C3300-201 | IRONWOOD PHARMACEUTICALS, INC | $2,100 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 39 | 48 | $23,280 | $3,541 |
| 2022 | 14 | 466 | 521 | $163,064 | $28,548 |
| 2021 | 16 | 533 | 629 | $203,976 | $39,547 |
| 2020 | 12 | 401 | 458 | $159,840 | $28,671 |
Total Patients
1,439
Total Services
1,656
Medicare Billing
$100,308
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 13 | 22 | $13,002 | $2,349 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $6,633 | $1,127 | 17.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 15 | 15 | $3,645 | $64.74 | 1.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 32 | 32 | $43,104 | $6,596 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 39 | 47 | $15,322 | $3,484 | 22.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 27 | 28 | $18,564 | $2,629 | 14.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 15 | 15 | $14,265 | $2,449 | 17.2% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 41 | 42 | $9,030 | $2,130 | 23.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $23,877 | $1,999 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 18 | $8,658 | $1,877 | 21.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 29 | $6,757 | $1,775 | 26.3% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Facility | 2022 | 168 | 202 | $6,868 | $1,642 | 23.9% |
| 91122 | Study of rectum sensitivity and function | Facility | 2022 | 21 | 21 | $6,090 | $1,433 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 24 | $5,304 | $1,272 | 24.0% |
| 91120 | Test for tone and sensation of rectum and anus | Facility | 2022 | 19 | 19 | $3,059 | $734.37 | 24.0% |
| 91034 | Monitoring and recording of esophageal function through nasal tube | Facility | 2022 | 12 | 12 | $1,968 | $476.41 | 24.2% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 11 | 11 | $198.00 | $50.92 | 25.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 33 | 33 | $44,451 | $7,468 | 16.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 34 | 54 | $17,472 | $4,598 | 26.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 30 | 37 | $17,571 | $4,424 | 25.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 33 | 33 | $37,521 | $3,841 | 10.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 21 | 21 | $19,971 | $3,770 | 18.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 30 | 32 | $21,216 | $3,107 | 14.6% |
| 91010 | Measurement of esophageal swallowing movement | Facility | 2021 | 48 | 48 | $10,320 | $2,794 | 27.1% |
| 91065 | Measurement of hydrogen in breath to test for gi symptoms | Facility | 2021 | 158 | 219 | $7,446 | $1,925 | 25.9% |
About Dr. Anthony Lembo, M.D
Dr. Anthony Lembo, M.D is a Gastroenterology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407826266.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Lembo, M.D has received a total of $115,904 in payments from pharmaceutical and medical device companies, with $5,598 received in 2024. These payments were reported across 69 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($83,510).
As a Medicare-enrolled provider, Lembo has provided services to 1,439 Medicare beneficiaries, totaling 1,656 services with total Medicare billing of $100,308. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Boston, MA
- Active Since 01/25/2006
- Last Updated 03/30/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1407826266
Products in Payments
- LINZESS (Drug) $24,952
- GIMOTI (Drug) $9,554
- IBSRELA (Drug) $6,206
- RELYVRIO (Drug) $5,250
- Entyvio (Biological) $5,000
- AMITIZA (Drug) $4,951
- MOTEGRITY (Drug) $3,210
- Sucraid (Drug) $3,000
- VELSIPITY (Drug) $3,000
- DAYBUE (Drug) $2,200
- Symproic (Drug) $1,579
- XIFAXAN (Drug) $584.76
- LINX Reflux Management System (Device) $217.33
- Vibrant Starter Kit (Device) $142.32
- Flat Wire Snares (Device) $127.06
- MB MMX (Drug) $99.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Boston
Dr. Hiroyuki Aihara, M.d, M.D
Gastroenterology — Payments: $1.0M
Gastroenterology $1.0M
Dr. Ramnik Xavier, Md, MD
Gastroenterology — Payments: $518,235
Gastroenterology $518,235
Adam Cheifetz, M.d, M.D
Gastroenterology — Payments: $435,150
Gastroenterology $435,150
Fredric Gordon, M.d, M.D
Gastroenterology — Payments: $280,379
Gastroenterology $280,379
Dr. Tyler Berzin, Md, MD
Gastroenterology — Payments: $230,903
Gastroenterology $230,903
Dr. Douglas Pleskow, M.d, M.D
Gastroenterology — Payments: $170,196
Gastroenterology $170,196